(Q48579262)

English

Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

1 reference

ChEBI release 2020-05-28

author name string

D A Decker

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

M Al Sarraf

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

C Kresge

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

D Austin

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

H I Wilner

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

publication date

1 January 1985

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

19-21

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

https://scigraph.springernature.com/pub.10.1007/bf00165167

0 references

Potential CNS Antitumor Agents VI: Aziridinylbenzoquinones III

1 reference

https://pubmed.ncbi.nlm.nih.gov/2987424

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2987424

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2987424

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2987424

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00165167

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2987424

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48579262&oldid=1381291588"